Annual Drug Patent Expirations for XERAVA
Xerava is a drug marketed by Tetraphase Pharms and is included in one NDA. There are two patents protecting this drug.
This drug has sixty-one patent family members in thirty countries.
The generic ingredient in XERAVA is eravacycline dihydrochloride. Additional details are available on the eravacycline dihydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
